Treatment of the Hematopoietic Syndrome

Evidence for the effectiveness of these agents comes from their use in cancer patients, human radiation accident victims, and animal studies. Filgrastim and sargramostim have hastened neutrophil recovery 3-6 days in patients following 

Proposed radiation Proposed radiation dose dose range for treat- range for treatment with ment with cytokines antibiotics  

Proposed radiation dose range for referral for SCT consideration 

7-10 for allogeneic SCT 4-10. If previous autograft stored or syngeneic donor available NA 

---